drugset / Trial / NCT05086445

A Study of LY3502970 in Japanese Participants With Type 2 Diabetes Mellitus

NCT05086445

Phase 1 Completed 62 enrolled Eli Lilly and Company
RandomizedParallel-groupDouble-blindBasic science

Summary

The main purpose of this study is to learn about the side effects of LY3502970 when given to Japanese participants with type 2 diabetes mellitus (T2DM). Blood tests will be performed to investigate how the body processes the study drug and how the study drug affects the body. For each participant, the study will last up to 24 weeks, inclusive of screening and will include 10 visits to the study center.

Timeline

Start
2021-11-12
Primary completion
2022-09-05
Completion
2022-09-05

Drugs

EvaluationDrugModalityDoseRoute
Subject Orforglipron Small molecule Oral